RWA
Ropes Wealth Advisors Portfolio holdings
AUM
$515M
This Quarter Return
+10.08%
1 Year Return
+21.76%
3 Year Return
+71.02%
5 Year Return
+189.07%
10 Year Return
–
AUM
$568M
AUM Growth
+$568M
(-8.9%)
Cap. Flow
-$86.3M
Cap. Flow
% of AUM
-15.19%
Top 10 Holdings %
Top 10 Hldgs %
32.8%
Holding
296
New
21
Increased
55
Reduced
128
Closed
27
Top Buys
| 1 |
Vanguard Small-Cap Growth ETF
VBK
|
$6.51M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$6.41M |
| 3 |
DraftKings
DKNG
|
$5.7M |
| 4 |
DocuSign
DOCU
|
$2.32M |
| 5 |
TechTarget
TTGT
|
$1.29M |
Top Sells
| 1 |
Moderna
MRNA
|
$43.6M |
| 2 |
Apple
AAPL
|
$5.11M |
| 3 |
Microsoft
MSFT
|
$4.4M |
| 4 |
Johnson & Johnson
JNJ
|
$2.23M |
| 5 |
NextEra Energy, Inc.
NEE
|
$2.12M |
Sector Composition
| 1 | Technology | 23.27% |
| 2 | Healthcare | 10.96% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.59% |
| 5 | Industrials | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Broadridge
BR
$29.5B
| $761K | 0.13% |
4,164
| – | – |
|
127
Blackstone
BX
$132B
| $759K | 0.13% |
5,868
+1,193
| +26% | +$154K |
|
128
Vanguard Real Estate ETF
VNQ
$34.1B
| $758K | 0.13% |
6,533
-583
| -8% | -$67.6K |
|
129
General Dynamics
GD
$87.3B
| $755K | 0.13% |
3,622
+79
| +2% | +$16.5K |
|
|
130
Moderna
MRNA
$9.41B
| $755K | 0.13% |
2,974
-171,808
| -98% | -$43.6M |
|
131
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.61B
| $746K | 0.13% |
14,100
| – | – |
|
132
iShares US Technology ETF
IYW
$22.7B
| $742K | 0.13% |
6,459
| – | – |
|
133
AT&T
T
$208B
| $733K | 0.13% |
29,783
-40,092
| -57% | -$987K |
|
134
Vanguard FTSE All-World ex-US ETF
VEU
$48.2B
| $727K | 0.13% |
11,868
+57
| +0.5% | +$3.49K |
|
135
iShares MSCI Emerging Markets ETF
EEM
$18.9B
| $715K | 0.13% |
14,636
-5
| -0% | -$244 |
|
136
DuPont de Nemours
DD
$31.7B
| $711K | 0.13% |
8,807
-3,470
| -28% | -$280K |
|
137
Thermo Fisher Scientific
TMO
$184B
| $701K | 0.12% |
1,051
+318
| +43% | +$212K |
|
138
Emerson Electric
EMR
$73.9B
| $700K | 0.12% |
7,527
+44
| +0.6% | +$4.09K |
|
139
Biogen
BIIB
$20.5B
| $695K | 0.12% |
2,898
-17
| -0.6% | -$4.08K |
|
140
iShares Core Dividend Growth ETF
DGRO
$33.5B
| $693K | 0.12% |
12,464
| – | – |
|
141
Broadcom
AVGO
$1.4T
| $677K | 0.12% |
1,017
+73
| +8% | +$48.6K |
|
142
Ameriprise Financial
AMP
$48.3B
| $666K | 0.12% |
2,208
| – | – |
|
143
BP
BP
$90.8B
| $641K | 0.11% |
24,089
-1,030
| -4% | -$27.4K |
|
144
Zoetis
ZTS
$67.8B
| $639K | 0.11% |
2,619
-831
| -24% | -$203K |
|
145
Brown-Forman Class A
BF.A
$14B
| $623K | 0.11% |
9,195
-149
| -2% | -$10.1K |
|
146
US Bancorp
USB
$75.5B
| $607K | 0.11% |
10,799
-6,393
| -37% | -$359K |
|
147
Exact Sciences
EXAS
$9.09B
| $600K | 0.11% |
+7,707
| New | +$600K |
|
148
Charles Schwab
SCHW
$174B
| $586K | 0.1% |
6,969
-16,169
| -70% | -$1.36M |
|
149
State Street
STT
$32.1B
| $586K | 0.1% |
6,302
-500
| -7% | -$46.5K |
|
150
iShares S&P 500 Growth ETF
IVW
$62.5B
| $583K | 0.1% |
6,968
+76
| +1% | +$6.36K |
|